M. Vugt

Literature Mining for the Discovery of Hidden Connections between Drugs, Genes and Diseases

Jacob de Vlieg, Ruben Smeets, Raoul Frijters, 2010, PLoS Comput. Biol..

Combination treatment of cis- and carboplatin in cancers restricted to the peritoneal cavity in the rat

J. Schornagel, H. Pinedo, M. Vugt, 2004, Cancer Chemotherapy and Pharmacology.

In vitro interaction of ACTH with rat brain muscarinic receptors

M. Vugt, J. Tonnaer, J. Graaf, 1986, Peptides.

Pharmacokinetics and Pharmacodynamics of the BACE1 Inhibitor Verubecestat (MK‐8931) in Healthy Japanese Adults: A Randomized, Placebo‐Controlled Study

Michael Tanen, M. Forman, M. Vugt, 2019, Clinical pharmacology and therapeutics.

Immunogenicity of pembrolizumab (pembro) in patients (pts) with advanced melanoma (MEL) and non-small cell lung cancer (NSCLC): Pooled results from KEYNOTE-001, 002, 006, and 010.

M. Vugt, F. Aarle, T. Freshwater, 2016 .

Adriamycin-loaded albumin-h~parin conjugate micros~h~r~s for intraperitoneal chemotherapy

J. Feijen, G. Kwon, M. Vugt, 1994 .

Population pharmacokinetic (popPK) model of pembrolizumab (pembro; MK-3475) in patients (pts) treated in KEYNOTE-001 and KEYNOTE-002.

A. Ribas, F. Hodi, C. Blank, 2015 .